Poster
Catherine C. Coombs, MD
University of California Irvine
Irvine, California, United States
Lindsey E. Roeker, MD
Senior Associate Consultant
Division of Hematology, Mayo Clinic
Rochester, Minnesota, United States
Joanna Rhodes, MD
Rutgers Cancer Institute of New Jersey, New Jersey, United States
Nilanjan Ghosh, PhD
Levine Cancer Institute, Atrium Health
Charlotte, North Carolina, United States
Beenish S. Manzoor, PhD, MPH
AbbVie Inc.
North Chicago, Illinois, United States
Nicole Lamanna, MD
Associate Professor
Columbia University Medical Center
New York, New York, United States
Toby A. A. Eyre, MRCP, FRCPath, MD
Consultant Haematologist
Churchill Hospital, Oxford University
Oxford, England, United Kingdom
Jennifer R. Brown, MD, PhD
Director, CLL Center, and Institute Physician; Worthington Margaret Collette Professor of Medicine in the Field of Hematologic Oncology
Dana-Farber Cancer Institute, Harvard Medical School
Boston, Massachusetts, United States
Nnadozie Emechebe, PhD, BPharm
AbbVie Inc.
North Chicago, Illinois, United States
Hande H. Tuncer, MD
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Nancy Kaddis, MD, MPH
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Chaitra Ujjani, MD
Fred Hutchinson Cancer Center / University of Washington School of Medicine, Washington, United States
Lori A Leslie, MD
John Theurer Cancer Center, Hackensack University Medical Center
Hackensack, New Jersey, United States
Brian T. Hill, MD, PhD
Cleveland Clinic
Cleveland, Ohio, United States
Alan Skarbnik, MD
Lymphoma and CLL Program, Novant Health Cancer Institute
Charlotte, North Carolina, United States
Paul M. Barr, MD
Professor of Medicine
Wilmot Cancer Institute / University of Rochester Medical Center
Rochester, New York, United States
Isabelle Fleury, MD, MSc
Doctor
Hôpital Maisonneuve-Rosemont, University of Montreal
Montreal, Quebec, Canada
Frederick Lansigan, MD
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Matthew S. Davids, MD, MMSc
Director, Clinical Research, Division of Lymphoma; Associate Professor of Medicine
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Christopher E. Jensen, MD
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Nicolas Martinez-Calle
Consultant Haematology
Nottingham University Hospitals, NHS Trust
Nottingham, England, United Kingdom
Wendy Sinai, PharmD
AbbVie, Inc.
North Chicago, Illinois, United States
Laurie Pearson, MD
University of Massachusetts
Worcester, Massachusetts, United States
Zhu Cui, MD
Tufts Medical Center
Boston, Massachusetts, United States
Michael Coyle, MD
Lowell General Hospital
Lowell, Massachusetts, United States
Bita Fakhri, MD, MPH
Stanford Cancer Institute, Stanford University
San Francisco, California, United States
Meghan C. Thompson
Fellow in Hematology & Medical Oncology
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Deborah M. Stephens, DO
Associate Professor; Director of the CLL and Richter Transformation Program
Lineberger Comprehensive Cancer Center, University of North Carolina
Chapel Hill, North Carolina, United States
Andres Chang, MD, PhD
Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
Samin Houshyar, MD
Wilmot Cancer Institute, University of Rochester Medical Center
Rochester, New York, United States
Anna Schuh, MD, PhD
Professor
Churchill Hospital, Oxford University
Oxford, England, United Kingdom
Irina Pivneva, PhD
Analysis Group, Inc.
Montreal, Canada
Talissa Watson, MSc
Analysis Group, Inc.
Montreal, Canada
Annie Guerin, MS
Analysis Group, Inc.
Montreal, Canada
Mazyar Shadman, MD, MPH
Professor
Fred Hutchinson Cancer Center
Seattle, Washington, United States